Skip to main content
 
Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Stanford Health Care

NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2025.

NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2025. Journal of the National Comprehensive Cancer Network : JNCCN Colevas, A. D., Cmelak, A. J., Pfister, D. G., Spencer, S., Adkins, D., Birkeland, A. C., Brizel, D. M., Busse, P. M., Caudell, J. J., Durm, G., Fakhry, C., Galloway, T., Geiger, J. L., Gillison, M. L., Glastonbury, C., Haddad, R. I., Hicks, W. L., Hitchcock, Y. J., Jimeno, A., Juloori, A., Kase, M., Leizman, D., Maghami, E., Mell, L. K., Mittal, B. B., Pinto, H. A., Price, K., Rocco, J. W., Rodriguez, C. P., Schwartz, D., Shah, J. P., Sher, D., John, M. S., Wang, H., Weinstein, G., Worden, F., Bruce, J. Y., Yom, S. S., Zhen, W., Montgomery, S., Darlow, S. D. 2025; 23 (2): 2-11

Abstract

The NCCN Guidelines for Head and Neck Cancers address tumors arising in the oral cavity (including mucosal lip), pharynx, larynx, and paranasal sinuses, as well as occult primary cancer, salivary gland cancer, and mucosal melanoma (MM). The specific site of disease, stage, and pathologic findings guide treatment (eg, the appropriate surgical procedure, radiation targets, dose and fractionation of radiation, indications for systemic therapy). The NCCN Head and Neck Cancers Panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. These NCCN Guidelines Insights summarize the panel's most recent recommendations regarding management of nasopharynx cancer and ongoing research in this area.

View details for DOI 10.6004/jnccn.2025.0007

View details for PubMedID 39938471